Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-122379
Filing Date
2025-12-16
Accepted
2025-12-16 17:41:35
Documents
1
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3138
  Complete submission text file 0001213900-25-122379.txt   4595
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Issuer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address
DOW GEOFFREY S (Reporting) CIK: 0001977231 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41719 | Film No.: 251576610